3D bioprinting technology could lead to personalized gastric cancer treatment

A collaborative research team from POSTECH has successfully developed a gastric cancer model using 3D bioprinting technology and patient-derived cancer tissue fragments. This innovative model preserves the characteristics of actual patient tissues and is expected to rapidly evaluate and predict individual patient drug responses. The research has been published in the journal Advanced Science.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup